Donald E. Bobo Jr - Jan 9, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP,Strategy/Corp Development
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: Jan 9, 2023
Transactions value $: -$284,490
Form type: 4
Date filed: 1/9/2023, 05:40 PM
Previous filing: Dec 12, 2022
Next filing: Feb 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$237K	+6.73K	+10.75%	$35.20	69.3K	Jan 9, 2023	Direct	F1
transaction	EW	Common Stock	Sale	-$521K	-6.73K	-9.71%	$77.50	62.6K	Jan 9, 2023	Direct	F1
holding	EW	Common Stock						38.3K	Jan 9, 2023	401(k)
holding	EW	Common Stock						117K	Jan 9, 2023	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-6.73K	-25%	$0.00	20.2K	Jan 9, 2023	Common Stock	6.73K	$35.20	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.